Definition of Recurrent Chronic Spontaneous Urticaria.
作者信息
Melé-Ninot Gemma, Serra-Baldrich Esther, Curto-Barredo Laia, Figueras-Nart Ignasi, Spertino Jorge, Expósito-Serrano Vicente, García-Navarro Xavier, Guilabert Antonio, Bielsa-Marsol Isabel, Giménez-Arnau Ana M
机构信息
Department of Dermatology, Hospital Universitari Sagrat Cor - Grupo Quirón Salud, ES-08029 Barcelona, Spain. E-mail:
出版信息
Acta Derm Venereol. 2020 Sep 23;100(16):adv00267. doi: 10.2340/00015555-3633.
Abstract
摘要
相似文献
1
Definition of Recurrent Chronic Spontaneous Urticaria.
Acta Derm Venereol. 2020 Sep 23;100(16):adv00267. doi: 10.2340/00015555-3633.
2
Omalizumab is effective in patients with chronic spontaneous urticaria plus multiple chronic inducible urticaria.
Eur Ann Allergy Clin Immunol. 2021 Mar;53(2):91-93. doi: 10.23822/EurAnnACI.1764-1489.153. Epub 2021 Mar 1.
3
Chronic spontaneous urticaria treated with omalizumab: what differentiates early from late responders?
Eur Ann Allergy Clin Immunol. 2021 Jan;53(1):47-48. doi: 10.23822/EurAnnACI.1764-1489.147. Epub 2021 Jan 7.
4
Omalizumab re-treatment rates in chronic spontaneous urticaria.
Eur Ann Allergy Clin Immunol. 2020 May;52(4):187-189. doi: 10.23822/EurAnnACI.1764-1489.145. Epub 2020 May 7.
5
Plasma adenosine is linked to disease activity and response to treatment in patients with chronic spontaneous urticaria.
Allergy. 2021 Feb;76(2):571-573. doi: 10.1111/all.14502. Epub 2020 Aug 5.
6
Real world evidence on treatment of chronic spontaneous urticaria with omalizumab: Preliminary data.
Dermatol Ther. 2020 Jul;33(4):e13458. doi: 10.1111/dth.13458. Epub 2020 Jun 7.
7
Safety of omalizumab treatment in patients with chronic spontaneous urticaria and COVID-19.
Dermatol Ther. 2021 Nov;34(6):e15111. doi: 10.1111/dth.15111. Epub 2021 Aug 31.
8
Children with chronic spontaneous urticaria: Recurrence after remission and its predictors.
J Allergy Clin Immunol Pract. 2020 Feb;8(2):796-798.e1. doi: 10.1016/j.jaip.2019.08.010. Epub 2019 Aug 16.
9
Chronic spontaneous urticaria refractory to cyclosporine add-on omalizumab successfully treated with methotrexate add-on.
Dermatol Ther. 2020 Nov;33(6):e14469. doi: 10.1111/dth.14469. Epub 2020 Nov 4.
10
Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three-month prospective study.
Clin Exp Allergy. 2022 May;52(5):715-718. doi: 10.1111/cea.14121. Epub 2022 Mar 22.
本文引用的文献
1
Chronic urticaria phenotypes: clinical differences regarding triggers, activity, prognosis and therapeutic response.
Eur J Dermatol. 2019 Dec 1;29(6):627-635. doi: 10.1684/ejd.2019.3674.
2
Clinical Features of Chronic Spontaneous Urticaria that Predict Disease Prognosis and Refractoriness to Standard Treatment.
Acta Derm Venereol. 2018 Jul 11;98(7):641-647. doi: 10.2340/00015555-2941.
3
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria.
Allergy. 2018 Jul;73(7):1393-1414. doi: 10.1111/all.13397.
4
Recurrence of Chronic Urticaria: Incidence and Associated Factors.
J Allergy Clin Immunol Pract. 2018 Mar-Apr;6(2):582-585. doi: 10.1016/j.jaip.2017.07.012. Epub 2017 Sep 6.
5
Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report.
Allergy. 2011 Mar;66(3):317-30. doi: 10.1111/j.1398-9995.2010.02496.x. Epub 2010 Nov 17.
Zotero 插件